The funding will be used by CytoSMART to further develop its microscopes and to expand its international sales and marketing strategies.

Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing.

New workflows for next-generation 4D metabolomics, leveraging routine, accurate and large-scale collision cross section (CCS) determinations on timsTOF Pro.

REDFINCH team achieves these capabilities in mid-infrared region, where many important chemical and biological species have strong absorption fingerprints.

AriaDNA real-time qPCR provides fast and easy-to-use microchip-based nucleic acid analysis.

Developing new automation options for QuantiFERON®-TB Gold Plus – the modern blood-based test for TB detection – and new QFT Access for high burden, low-resource regions.

Amazon Filters reports on how a leading Animal Healthcare company has made significant time and cost savings through implementation of a SupaPore 16FPW microfiltration system for bioburden control on its 100m3 batch production of an enzyme added to chicken feed.

A new paradigm in light scattering technology.

New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis.

Under the terms of the agreement, Domainex will enrich its existing fragment collection with a diverse set of SpiroChem fragments that it will screen with its highly efficient and cost-effective FragmentBuilder platform.